What is Boston Scientific's market cap?

Boston Scientific (BSX) has a market capitalization of $66.6B and trades on NYSE.

What is Boston Scientific's revenue and profitability?

Boston Scientific generated $20.6B in trailing twelve-month revenue with net income of $3.6B, representing a net margin of 17.3%. Gross margin stands at 69.2%, with free cash flow of $3.5B. These figures are based on the Q1 2026 filing.

Who are Boston Scientific's competitors?

Boston Scientific's key competitors include Medtronic plc, Abbott Laboratories, Stryker Corporation, and others. These companies compete in similar markets and product categories.

What subsidiaries does Boston Scientific have?

Boston Scientific's subsidiaries include Bolt Medical, Inc., SoniVie Ltd., Penumbra, Inc., and others.

Where is Boston Scientific headquartered?

Boston Scientific is headquartered in United States of America and employs approximately 48,000 people. It has been publicly traded since 1992.

Boston Scientific

BSX

Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices used across various interventional medical specialties.

Market cap

$66.6B-56.8%

Revenue$20.6B+17.4%

Net income$3.6B+75.8%

Free cash flow$3.5B+15.3%

EPS (diluted)$2.39+74.5%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 22, 2026

Revenue$5.2BBeat by $30.1M EPS$0.80Beat by $0.01

Read the full report

Next report

Jul 29, 2026 (In 2 weeks)

Revenue estimate$5.4B

EPS estimate$0.83

Financials

Q1 2026

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation & ratios

Valuation

See full

Market cap$66.6B-56.8%

P/E18.7×-43.1×

P/S3.2×-5.1×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Current ratio1.9×+0.4×

Segments

By product

See full

Interventional Cardiology & Vascular Therapies$1.2B—

Electrophysiology$905.0M+24.0%

Endoscopy$736.0M+9.4%

Urology$646.0M+2.1%

Cardiac Rhythm Management$578.0M0.0%

By geography

See full

Europe, Middle East and Africa$932.0M+10.2%

Asia-Pacific$803.0M+14.6%

Latin America and Canada$185.0M+19.4%

By segment

See full

Cardiovascular$3.5B+13.5%

MedSurg$1.7B+7.9%

Competitors

By market cap

Johnson & Johnson$634.06B+68.9%

Abbott$165.79B-29.1%

Stryker$125.30B-17.1%

Medtronic$104.98B-7.3%

Boston Scientific$66.6B-56.8%

Edwards Lifesciences$53.9B+19.7%

Merit Medical Systems$4.2B-23.4%

IAR

Integra LifeSciences$1.3B+28.4%

By revenue growth

Boston Scientific+17.4%

Edwards Lifesciences+14.1%

Merit Medical Systems+11.1%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+7.9%

Abbott+6.6%

IAR

Integra LifeSciences+1.2%

By net margin

Johnson & Johnson21.83%-2.6pp

Edwards Lifesciences17.39%-58.3pp

Boston Scientific17.26%+5.7pp

Abbott13.91%-18.0pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Merit Medical Systems9.03%+0.2pp

IAR

Integra LifeSciences-30.15%-27.0pp

Profile

Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices used across various interventional medical specialties. The company focuses on less-invasive medical solutions that serve as alternatives to traditional surgery, aiming to improve patient outcomes while reducing healthcare costs. Its portfolio addresses complex conditions in cardiovascular, respiratory, digestive, oncological, neurological, and urological medicine.

Competitive position

A leading global medical technology provider specializing in category leadership through high-growth adjacencies and less-invasive procedural innovation.

GeographiesGlobal, United States, China, Japan, Europe

Customer segmentsHospitals, Specialist Physicians, Ambulatory Surgery Centers, Group Purchasing Organizations

Business modelManufacturing, Direct Sales, Research and Development

SuppliersRaw material suppliers, Specialized component manufacturers, Sterilization service providers, Research institutions and universities

CustomersHospitals, Clinics, Medical offices, Group Purchasing Organizations (GPOs), Third-party distributors

CountryUnited States of America

Listed1992

Employees48.0K

CEOMichael F. Mahoney

SectorHealthcare

IndustryMedical - Devices

Websitebostonscientific.com

FilingsSEC EDGAR

Ask your AI about Boston Scientific.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's market cap?: Boston Scientific (BSX) has a market capitalization of $66.6B and trades on NYSE.
What is Boston Scientific's revenue and profitability?: Boston Scientific generated $20.6B in trailing twelve-month revenue with net income of $3.6B, representing a net margin of 17.3%. Gross margin stands at 69.2%, with free cash flow of $3.5B. These figures are based on the Q1 2026 filing.
Who are Boston Scientific's competitors?: Boston Scientific's key competitors include Medtronic plc, Abbott Laboratories, Stryker Corporation, and others. These companies compete in similar markets and product categories.
What subsidiaries does Boston Scientific have?: Boston Scientific's subsidiaries include Bolt Medical, Inc., SoniVie Ltd., Penumbra, Inc., and others.
Where is Boston Scientific headquartered?: Boston Scientific is headquartered in United States of America and employs approximately 48,000 people. It has been publicly traded since 1992.